Private Equity

Angel Investments

Neuro-health player In-Med Prognostics raises $2.13 M led by Exxora

Press Release  

Pune-based In-Med Prognostics, which offers multi-modal data and image processing, has raised USD 2.13 million led by Exxora with participation from angels. The funds will be used to stabilize and expand the product portfolio and tap global markets. In-Med Prognostics leverages deep learning algorithms and machine learning to aid in assessment and early detection of neurological disorders such as dementia, Alzheimer's and Parkinson's at affordable prices. Their ‘neuroshield' solution provides a self-explanatory volumetric report within 20 minutes. It offers image processing to software to help neurologists take decisions and radiologists in workflow enhancement. The company also provides ethnicity-specific neuro assessment reports and multi-modal data processing capability to develop integrated digital biomarkers. In-Med India was founded in 2018 and had announced a INR 50 lakh Grant from BIRAC in 2019. In-Med Inc, the US holding company was formed in 2021. The company has since secured global IP. The company has also expanded its footprint to Africa.